2-(bis-(hydroxyethyl)amino)-6-(4-methoxybenzylamino)-9-isopropyl-purine,
CVT 313,
CVT-313,
CVT-313,
199986-75-9,
Cdk2 Inhibitor III,
AC1OCFD4,
UNII-T5490K8I7S,
CVT 313,
CHEMBL80713,
T5490K8I7S,
2(bis-(Hydroxyethyl)amino)-6-(4-methoxybenzylamino)-9-isopropyl-purine,
2-[2-hydroxyethyl-[6-[(4-methoxyphenyl)methylamino]-9-propan-2-ylpurin-2-yl]amino]ethanol,
2-[(2-hydroxyethyl)(6-{[(4-methoxyphenyl)methyl]amino}-9-(propan-2-yl)-9H-purin-2-yl)amino]ethan-1-ol,
Ethanol, 2,2'-((6-(((4-methoxyphenyl)methyl)amino)-9-(1-methylethyl)-9H-purin-2-yl)imino)bis-,
NG 26,
NG-36,
Ethanol, 2,2'-[[6-[[(4-methoxyphenyl)methyl]amino]-9-(1-methylethyl)-9H-purin-2-yl]imino]bis-,
GTPL5948,
NG26,
SCHEMBL1394958,
CTK8F1270,
DTXSID30173812,
HMS3229E16,
BCP17295,
EX-A1225,
ZINC1487345,
CVT-313(NG-26),
3564AH,
BDBM50113739,
HSCI1_000262,
IN1370,
MFCD06411412,
AKOS027257517,
CCG-206835,
CS-0881,
NCGC00379012-01,
AK213292,
HY-15339,
RT-012111,
W-5332,
J-012931,
2-(bis-(hydroxylethyl)amino)-6-(4-methoxybenzylamino)-9-isopropylpurine,
2,2'-((9-Isopropyl-6-((4-methoxybenzyl)amino)-9H-purin-2-yl)azanediyl)diethanol,
2,2'-(9-Isopropyl-6-(4-methoxybenzylamino)-9H-purin-2-ylazanediyl)diethanol,
2-{(2-Hydroxy-ethyl)-[9-isopropyl-6-(4-methoxy-benzylamino)-9H-purin-2-yl]-amino}-ethanol,
2,2'-[[6-[[(4-Methoxyphenyl)methyl]amino]-9-(1-methylethyl)-9H-purin-2-yl]imino]bis[ethanol],
D0P2WA,
C20H28N6O3,
CID6918386,
A3336,
A15054,
C109140,
2-(bis-(hydroxyethyl)amino)-6-(4-methoxybenzylamino)-9-isopropyl-purine,